Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. Tomorrow, March 6, 2013, 43 U.S. common stocks are scheduled to go ex-dividend. The dividend yields on these stocks range from 0.1% to 9.7%. All of these stocks can be found on our stocks going ex-dividend section of our dividend calendar. Highlighted Stocks Going Ex-Dividend Tomorrow:
Owners of Shire (NASDAQ: SHPG) shares as of market close today will be eligible for a dividend of 44 cents per share. At a price of $95.21 as of 9:36 a.m. ET, the dividend yield is 0.5%. The average volume for Shire has been 327,900 shares per day over the past 30 days. Shire has a market cap of $18.1 billion and is part of the drugs industry. Shares are up 3.3% year to date as of the close of trading on Monday. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys dividend stocks that have the potential for a 3% to 4% yield and 10% growth. Get his best picks for less than $50/year. Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in three segments: Specialty Pharmaceuticals, Human Genetic Therapies, and Regenerative Medicine. The company has a P/E ratio of 24.50. Currently there are 11 analysts that rate Shire a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Shire as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Shire Ratings Report now.